BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.26% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSFG
4301
DELISTED
First Savings Financial Group
FSFG
| $970K | ﹤0.01% |
40,507
-10,266
| -20% | -$251K |
|
|
ZYNE
4302
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $962K | ﹤0.01% |
843,683
+5,224
| +0.6% | +$6.65K |
|
|
CGRN
4303
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $962K | ﹤0.01% |
389,658
-3,852
| -1% | -$11.8K |
|
4304
RF Industries
RFIL
$134M
| $960K | ﹤0.01% |
154,728
-2,303
| -1% | -$14.8K |
|
4305
Aware
AWRE
$26M
| $959K | ﹤0.01% |
402,858
+1,170
| +0.3% | +$3.11K |
|
4306
Transact Technologies
TACT
$53.2M
| $958K | ﹤0.01% |
240,825
-2,636
| -1% | -$14.6K |
|
4307
Dianthus Therapeutics
DNTH
$5.84B
| $955K | ﹤0.01% |
49,710
-83,859
| -63% | -$2.07M |
|
|
NHS
4308
Neuberger High Yield Strategies Fund Inc
NHS
$251M
| $954K | ﹤0.01% |
+113,900
| New | +$1.08M |
|
4309
Biglari Holdings Class A
BH.A
$1.25B
| $948K | ﹤0.01% |
1,613
-11
| -0.7% | -$7.27K |
|
4310
Escalade
ESCA
$273M
| $947K | ﹤0.01% |
72,936
-484,309
| -87% | -$6.34M |
|
|
LITS
4311
Lite Strategy Inc
LITS
$32.8M
| $943K | ﹤0.01% |
77,935
-265,436
| -77% | -$2.89M |
|
|
SIEN
4312
DELISTED
Sientra, Inc.
SIEN
| $942K | ﹤0.01% |
112,586
-264,268
| -70% | -$3.6M |
|
4313
Neurogene
NGNE
$656M
| $938K | ﹤0.01% |
45,542
-82,382
| -64% | -$2.01M |
|
|
CDAK
4314
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $936K | ﹤0.01% |
325,183
-709,012
| -69% | -$2.49M |
|
|
KIO
4315
KKR Income Opportunities Fund
KIO
$451M
| $935K | ﹤0.01% |
+80,300
| New | +$1.05M |
|
4316
NetSol Technologies
NTWK
$51.2M
| $933K | ﹤0.01% |
292,806
+443
| +0.2% | +$1.53K |
|
|
MRDN
4317
Meridian Holdings Inc
MRDN
$143M
| $932K | ﹤0.01% |
+17,344
| New | +$1.02M |
|
|
BLDP
4318
Ballard Power Systems
BLDP
$805M
| $931K | ﹤0.01% |
147,838
-4,386,095
| -97% | -$35.1M |
|
|
HEPA
4319
DELISTED
Hepion Pharmaceuticals
HEPA
| $924K | ﹤0.01% |
1,615
+2
| +0.1% | +$1.67K |
|
|
SAL
4320
DELISTED
Salisbury Bancorp, Inc.
SAL
| $924K | ﹤0.01% |
39,132
-1,866
| -5% | -$48.5K |
|
4321
Bolt Biotherapeutics
BOLT
$7.67M
| $918K | ﹤0.01% |
22,517
-58,102
| -72% | -$2.26M |
|
4322
FerroAtlántica
GSM
$594M
| $917K | ﹤0.01% |
154,437
-34,144
| -18% | -$240K |
|
|
BFX
4323
DELISTED
BowFlex Inc.
BFX
| $916K | ﹤0.01% |
522,982
-1,469,969
| -74% | -$4.06M |
|
4324
Mannatech
MTEX
$9.24M
| $913K | ﹤0.01% |
55,336
-48
| -0.1% | -$1.31K |
|
4325
iShares iBonds Dec 2029 Term Treasury ETF
IBTJ
$1.31B
| $910K | ﹤0.01% |
40,000
| – | – |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,355 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.